The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year

1989

Stage

Series C | Dead

Total Raised

$5.3M

Last Raised

$2M

About Medclone

Developer of disease-specific therapies for treatment of autoimmune diseases. Initial compounds are vaccines and passive immunotherapies for systemic lupus erythematosus (SLE) and rheumatoid arthritis. MedClone's therapeutic approach identifies the specific autoantigen that is the target of the autoimmune response or the pathogenic autoantibody that is produced in such a response. Once identified, the pathogenic autoantibody can be used as a vaccine to induce the production of anti-ideotype antibodies that will down regulate the disease. To date MedClone has identified a pathogenic autoantibody (MAb 3E10) and its anti-ideotype (MAb 1C7), involved in lupus nephritis. Publicly presented human clinical data is now available which demonstrates the safety and efficacy of MAb 3E10 for treating lupus nephritis and MAb 3E10 has been granted Orphan Drug Designation. Company has also identified a human autoantibody (HRF1) believed to be involved in the pathogenesis of rheumatoid arthritis. Invesco has committed $500,000 to the current round of financing.

Medclone Headquarter Location

2435 Military Avenue

Los Angeles, California, 90064,

United States

(310)914-7865

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was Medclone founded?

    Medclone was founded in 1989.

  • Where is Medclone's headquarters?

    Medclone's headquarters is located at 2435 Military Avenue, Los Angeles.

  • What is Medclone's latest funding round?

    Medclone's latest funding round is Series C.

  • How much did Medclone raise?

    Medclone raised a total of $5.3M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.